Table of Contents
Library Preparation and Target Enrichment technologies are a necessary part of the sequencer's use in clinical applications. As the sequencer technologies become cheaper, they have been increasingly moving into more labs and new types of research projects in a virtuous cycle. The capabilities of next-generation sequencer (NGS) systems, along with the growing availability of vast amounts of annotated sequence data, have permitted life science researchers to undertake a much wider range of experiments. The diverse needs of these experiments have resulted in a high demand for library preparation and target enrichment products.
This report, Library Preparation and Target Enrichment for Next Generation Sequencing Product Markets contains valuable information on the current state of LP/TE for next generation sequencing including:
Market Size and Forecasts for Library Prep and Target Enrichment
Market Share and Competitive Analysis
Over 340 Deals, Collaborations and Partnerships Since 2010 involving LP/TE.
Library Preparation and Target Enrichment Products Launched Since 2012
Important Trends in the Industry
Litigation and Intellectual Property Review
Analyst's Conclusions and Recommendations
DNA and RNA sequencing are becoming more central components of life science research. In addition to their prices dropping, the technologies continue to rapidly improve and become more user-friendly. The applications of sequencing span a broad range of industries and specializations, but the focus has mostly been life science research-related. As the science becomes more established, various clinical applications have become proven, and there are certain areas such as cancer where there are expected to be rapidly growing benefits in the near future.
The NGS systems are capable of a wide range of applications, and labs have taken advantage of their flexibility. The same system is often used for five or ten distinct applications. The NGS systems also have specific constraints on the type of sample that can be loaded, with regard to fragment size, adapters, and the like. The protocols can sometimes require several steps. These factors have created a market for a large range of products catering to all of the different variations of these numerous applications.
As part of its coverage of the report, several major competitors are profiled. Companies profiled in the report are
F. Hoffmann-La Roche AG
Thermo Fisher Scientific
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
The global non-invasive prenatal testing (NIPT) market is projected to reach USD 2.88 billion by 2021 from USD 1.35 billion in 2016, at a CAGR of 16.4% from 2016 to 2021. The major factors driving the ...
The global next-generation sequencing market is estimated to register a CAGR of 20.5% from 2017 to 2022 to reach USD 12.45 billion by 2022. Factors such as technological advancements in NGS platforms, ...
The global high throughput process development market is expected to reach USD 19.78 billion in 2021 from USD 9.91 billion in 2016, at a CAGR of 14.8% from 2016 to 2021. Growth in the high throughput process ...